Close Menu
    What's Hot

    JAB Insurance completes acquisition of Utmost Life and Pensions

    October 29, 2026
    Milliman

    Competitive US Pension Risk Transfer Cost Decreases During September

    October 28, 2026

    New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

    October 28, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Symetra and TIAA Partner To Launch Mariner Re

      October 27, 2026

      Chariot Re Announces Fourth Reinsurance Transaction, First Covering Japanese Liabilities

      October 15, 2026

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026

      Is Dementia the Next Big Longevity Event?

      October 15, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      JAB Insurance completes acquisition of Utmost Life and Pensions

      October 29, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreases During September

      October 28, 2026

      New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

      October 28, 2026

      Interface Europe Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      October 22, 2026

      Record Low Mortality Rates So Far in 2026 in England and Wales, Says CMI

      October 12, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Household Capital Completes New Reverse Mortgage Securitisation

      October 22, 2026

      New Report Suggests Life Settlement Market Poised for Long-Term Expansion

      October 15, 2026

      Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

      October 15, 2026

      Global Equity Release Market Estimated To Hit $52 Billion by 2035

      October 12, 2026

      JAB Insurance completes acquisition of Utmost Life and Pensions

      October 29, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreases During September

      October 28, 2026

      New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

      October 28, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026
    • Events
    • Latest Issues
      Life Risk News Editors Letter

      Editor’s Letter – Volume 2, Issue 10, October 2026

      October 15, 2026

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Ailish Finnerty, Partner, Arthur Cox 

    Secondary Life Markets May 10, 2024By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    Life settlement funds have long enjoyed a home in Ireland. Greg Winterton caught up with Ailish Finnerty, Partner at law firm Arthur Cox, to learn more about why, and whether the trend will persist. 

    GW: Ailish, let’s start with the obvious. Why do so many life settlement funds call Ireland home? 

    AF: US life settlement portfolios represent a very attractive investment to US and non-US investors alike. In bringing investors together, a key focus of the asset manager will be to ensure the fund is located in a favourable jurisdiction that has a long established and well-respected legal regime in the investment fund area. In addition, the fund itself must be tax efficient, ideally with no withholding tax on payment of maturities from the US insurer to the fund, no material tax leakage at the level of the fund itself and no withholding taxes on payments of returns to the US and non-US investors.  

    Ireland is an obvious choice here. The Irish ICAV and Irish Section 110 company are long established and present a tried and tested solution to all the issues highlighted above.   

    GW: Your expertise is in corporate tax planning. Is there anything on your radar from a regulatory perspective that is coming up that might impact the life settlement market? 

    AF: We advise only on Irish legal and tax issues in establishing and maintaining Irish vehicles to hold life settlement portfolios. As such, we cannot comment on any regulatory issues in other jurisdictions (e.g. the US, where the policies are sourced). From an Irish perspective, changes of law in the tax arena are of relevance and, if the portfolio is held via an Irish ICAV (which is a vehicle regulated by the Central Bank of Ireland (“CBI”), any changes in the regulatory regime applicable to ICAVs are of interest also. The Section 110 company is mainly outside the regulatory framework of the CBI and therefore is less likely to be impacted by regulatory change.  

    In the tax space, the BEPS initiative (introduced in the EU via the Anti-Tax Avoidance Directives) introduced, among other things, anti-hybrid rules and interest limitation rules that impacted the tax treatment of Section 110 companies. In some cases, those tax changes mean that the structure is better housed in an ICAV (which is exempt from tax in Ireland in these circumstances) and we helped our clients migrate across from a Section 110 company to an ICAV in those cases.   

    From the perspective of the CBI, there was a period around 2020/2021 when life settlement funds were attracting more scrutiny in the approval process, as the CBI sought to understand the asset class and why they were seeing so much interest in Ireland for these structures. We worked with our clients to assist the CBI in answering questions raised and ultimately to get them comfortable and in the past couple of years, the CBI is back to its usual process of granting approval within 24 hours. Although fund regulation in Europe is a constantly developing area, we don’t see anything on the horizon that would fundamentally change the way life settlement structures are regulated in Ireland. 

    GW: In mid-July 2022, the Central Bank of Ireland changed its pre-submission process for a Qualifying Investor AIF, which, for the life settlement industry, meant that applications could be fast-tracked. Almost two years on, has this had much of an impact on fund launches? 

    AF: Yes, the removal of the pre-submission process for life settlements and the return to the normal QIAIF filing process and timelines has certainly allowed institutional managers to launch their strategies in a very timely manner and has facilitated managers in more accurately timing the launch of their funds with the closure of portfolio acquisitions.   

    GW: There has been anecdotal evidence to suggest that more life settlement asset managers are launching closed-ended funds, as opposed to open-ended ones. What are some of the tax implications that a manager and/or an investor should be conscious of here? 

    AF: Happily, being either closed-ended or open-ended does not impact the Irish tax treatment of the vehicle although it is noted that from a liquidity management perspective most managers find that closed ended structures are more suitable to this type of less liquid asset. Being closed-ended doesn’t prevent distributions to shareholders on maturities but does protect the structure from liquidity pressures. 

    GW: A cynic would say that tax is the main driver of investment fund returns, not the strategy employed by the investment manager. What’s your message to end investors that are considering allocating to life settlement funds in terms of the impact of tax? 

    AF: Make sure you are getting the right advice! Ensuring the life settlement portfolio is housed in a well-structured Irish vehicle that benefits from the Ireland/US tax treaty, you should be able to avoid any tax leakage in getting maturities out of the US, in the vehicle itself and in getting returns to investors. Clearly, local law advice where the investor is located will be critical also to optimise the status of the returns earned.  

    Ailish Finnerty is a Partner at Arthur Cox LLP.

    2024 - May Life Settlements Longevity Risk Q&A Volume 3 Issue 5 - May 2024
    Share. Twitter LinkedIn Email

    Related Posts

    New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

    October 28, 2026By Greg Winterton

    Q&A: Alexandr Dudarev, CEO, Inshurik

    October 28, 2026By Greg Winterton

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026By Greg Winterton

    Conning Forecasts Long-Term Expansion for US Life Settlement Market

    October 12, 2026By LMI Newsdesk
    Latest Issue

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026

    Is Dementia the Next Big Longevity Event?

    October 15, 2026

    Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

    October 15, 2026

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.